Tumor Mutational Burden From Tumor-Only Sequencing Compared With Germline Subtraction From Paired Tumor and Normal Specimens

IMPORTANCE: Tumor mutation burden (TMB) is an emerging factor associated with survival with immunotherapy. When tumor-normal pairs are available, TMB is determined by calculating the difference between somatic and germline sequences. In the case of commonly used tumor-only sequencing, additional ste...

Descripción completa

Detalles Bibliográficos
Autores principales: Parikh, Kaushal, Huether, Robert, White, Kevin, Hoskinson, Derick, Beaubier, Nike, Dong, Haidong, Adjei, Alex A., Mansfield, Aaron S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Medical Association 2020
Materias:
Original Investigation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7049088/
https://www.ncbi.nlm.nih.gov/pubmed/32108894
http://dx.doi.org/10.1001/jamanetworkopen.2020.0202

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7049088/
https://www.ncbi.nlm.nih.gov/pubmed/32108894
http://dx.doi.org/10.1001/jamanetworkopen.2020.0202

Ejemplares similares